Literature DB >> 11723367

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

L E Hebert1, L A Beckett, P A Scherr, D A Evans.   

Abstract

Alzheimer disease will affect increasing numbers of people as baby boomers (persons born between 1946 and 1964) age. This work reports projections of the incidence of Alzheimer disease(AD) that will occur among older Americans in the future. Education adjusted age-specific incidence rates of clinically diagnosed probable AD were obtained from stratified random samples of residents 65 years of age and older in a geographically defined community. These rates were applied to U.S. Census Bureau projections of the total U.S. population by age and sex to estimate the number of people newly affected each year. The annual number of incident cases is expected to more than double by the midpoint of the twenty-first century: from 377,000 (95% confidence interval = 159,000-595,000) in 1995 to 959,000 (95% confidence interval = 140,000-1,778,000) in 2050. The proportion of new onset cases who are age 85 or older will increase from 40% in 1995 to 62% in 2050 when the youngest of the baby boomers will attain that age. Without progress in preventing or delaying onset of Alzheimer disease, both the number of people with Alzheimer disease and the proportion of the total population affected will increase substantially.

Entities:  

Mesh:

Year:  2001        PMID: 11723367     DOI: 10.1097/00002093-200110000-00002

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  129 in total

1.  3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Authors:  Liana G Apostolova; Kristy S Hwang; John P Andrawis; Amity E Green; Sona Babakchanian; Jonathan H Morra; Jeffrey L Cummings; Arthur W Toga; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Ronald C Petersen; Paul S Aisen; William J Jagust; Robert A Koeppe; Chester A Mathis; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

2.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

3.  Semi-supervised pattern classification of medical images: application to mild cognitive impairment (MCI).

Authors:  Roman Filipovych; Christos Davatzikos
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

4.  Flavonoids and isoflavonoids: from plant biology to agriculture and neuroscience.

Authors:  Richard A Dixon; Giulio M Pasinetti
Journal:  Plant Physiol       Date:  2010-10       Impact factor: 8.340

5.  Design of comprehensive Alzheimer's disease centers to address unmet national needs.

Authors:  John Q Trojanowski; Steven E Arnold; Jason H Karlawish; Kurt Brunden; Mark Cary; Christos Davatzikos; John Detre; Glen Gaulton; Murray Grossman; Howard Hurtig; Kathryn Jedrziewski; Leo McCluskey; Mary Naylor; Daniel Polsky; Gerard D Schellenberg; Andrew Siderowf; Leslie M Shaw; Vivianna Van Deerlin; Li-San Wang; Rachel Werner; Sharon X Xie; Virginia M-Y Lee
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

6.  Graph-guided joint prediction of class label and clinical scores for the Alzheimer's disease.

Authors:  Guan Yu; Yufeng Liu; Dinggang Shen
Journal:  Brain Struct Funct       Date:  2015-10-17       Impact factor: 3.270

Review 7.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

8.  AAC to support conversation in persons with moderate Alzheimer's disease.

Authors:  Melanie Fried-Oken; Charity Rowland; Darlene Daniels; Mayling Dixon; Bret Fuller; Carolyn Mills; Glory Noethe; Jeon Small; Kevin Still; Barry Oken
Journal:  Augment Altern Commun       Date:  2012-12       Impact factor: 2.214

9.  Documentation of antipsychotic use and indications for newly diagnosed, nonaggressive dementia patients.

Authors:  Nikhil Dhawan; Avila B Steele; Robert O Morgan; A Lynn Snow; Jessica A Davila; Mark E Kunik
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  The secure base script and the task of caring for elderly parents: implications for attachment theory and clinical practice.

Authors:  Cory K Chen; Harriet Salatas Waters; Marilyn Hartman; Sheryl Zimmerman; David J Miklowitz; Everett Waters
Journal:  Attach Hum Dev       Date:  2013-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.